AAV Gene Therapy
Developing effective and reproducible gene therapies while ensuring safety and effectiveness in patients is complex, and there is no room for error. Bio-Rad’s portfolio of Droplet Digital PCR (ddPCR) products for AAV Gene Therapy utilize the precision and sensitivity of ddPCR technology and work seamlessly with each other, offering a complete ddPCR workflow solution to check the quality of your therapeutic product.
AAV Viral Titer Workflow Solution
MOgene’s complete AAV Viral Titer Workflow Solution offers custom and ready-to-order ddPCR Assays. The solution is an optimized protocol to help you start-all reagents and consumables required for an end-to-end ddPCR workflow, instrument platforms-including the QX ONE ddPCR System, our flagship system expertly designed for Biopharma manufacturing, and software packages that enable regulatory compliance. When used together, these products deliver a precise and convenient solution to help you validate the quality of your therapeutic product with confidence.
Benefits of having a validated system for performing quality control on your samples
The ddPCR assay development system has been validated, so it is a faster, less costly alternative to send samples off for analysis with outside testing facilities. This system allows scientists to have GMP quality control on their samples without going through long protocols of sending out samples to outdoor testing facilities.